已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Pre-infusion 18F-FDG PET/CT for Prognostic and Toxicity Prediction in B-cell Non-Hodgkin Lymphoma Patients Undergoing Chimeric Antigen Receptor T-cell Therapy

医学 标准摄取值 淋巴瘤 核医学 正电子发射断层摄影术 内科学 放射治疗 挽救疗法 肿瘤科 胃肠病学 化疗
作者
Xilan Yao,Hongrong Wang,Xiao Lei,Shuang Yao,Wei Wang,Jigang Yang
出处
期刊:Clinical Nuclear Medicine [Lippincott Williams & Wilkins]
卷期号:50 (6): 501-507 被引量:1
标识
DOI:10.1097/rlu.0000000000005888
摘要

PURPOSE: The aim of this study was to evaluate the value of 18 F-FDG PET/CT in predicting outcomes and toxicity for patients with B-cell non-Hodgkin lymphoma (B-NHL) who underwent chimeric antigen receptor T (CAR-T) cell therapy. METHODS: This retrospective study included B-NHL patients who underwent CAR-T therapy and had pre-infusion 18 F-FDG PET/CT images. We recorded SUVmax, metabolic tumor volume (MTV), total lesion glycolysis (TLG), and various clinical and laboratory indexes. The primary endpoints were progression-free survival (PFS) and overall survival (OS). PFS and OS were estimated using the Kaplan-Meier method. In addition, we reported the correlation between PET/CT parameters and the objective response (OR), as well as cytokine release syndrome (CRS). RESULTS: A total of 133 patients were enrolled in this study. The median follow-up duration was 20.8 months. SUVmax (with a cutoff value of 15.65) emerged as an independent metabolic parameter associated with PFS, OS, and OR. Patients with SUVmax ≥15.65 had a median PFS of 9.13 months (95% CI: 0.11-18.16), while the PFS for those with SUVmax<15.65 was not reached ( P =0.006). Furthermore, patients with SUVmax ≥15.65 exhibited significantly shorter average OS compared with those with SUVmax<15.65 (26.89 mo vs. 45.14 mo, P =0.010). In addition, the odds ratio for achieving an OR in patients with SUVmax ≥15.65 was found to be lower at 0.173 (95% CI: 0.056-0.539). Other factors associated with PFS included ECOG-PS, B symptoms, bulky mass, and extranodal sites, whereas IPI and LDH were associated with OS. Furthermore, SUVmax and Deauville scores showed a weak positive correlation with the occurrence of CRS. CONCLUSIONS: The pretreatment PET/CT parameter SUVmax appears to be a promising predictive factor for efficacy and prognosis, as well as being associated with the occurrence of CRS. Consequently, we can conclude that this metabolic parameter from pretreatment PET/CT scans may serve as a valuable tool in guiding patient selection for CAR-T therapy and predicting potential side effects.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
369ninja发布了新的文献求助10
2秒前
一点通完成签到 ,获得积分10
4秒前
23发布了新的文献求助10
5秒前
5秒前
6秒前
7秒前
寂静王完成签到 ,获得积分10
7秒前
Nole完成签到,获得积分0
7秒前
在读芝士青年完成签到 ,获得积分10
8秒前
molihuakai的应助被Jason采纳,获得10
8秒前
mimi完成签到 ,获得积分10
9秒前
云珀千完成签到 ,获得积分10
12秒前
孤独的万恶完成签到 ,获得积分10
12秒前
12秒前
15秒前
Jason完成签到,获得积分10
16秒前
俏皮的浩宇完成签到,获得积分10
16秒前
李S完成签到 ,获得积分10
19秒前
Ava的应助被糊涂的大门采纳,获得10
19秒前
21秒前
lyp完成签到 ,获得积分10
23秒前
欢喜的听南完成签到,获得积分10
24秒前
汉堡包的应助被aioujj采纳,获得10
24秒前
烟花的应助被wise111采纳,获得10
24秒前
24秒前
su发布了新的文献求助10
25秒前
28秒前
C胖胖完成签到,获得积分10
29秒前
29秒前
29秒前
30秒前
这样说话发布了新的文献求助10
33秒前
jjjj完成签到,获得积分10
35秒前
cjy完成签到 ,获得积分10
35秒前
35秒前
36秒前
36秒前
田様的应助被zyy采纳,获得10
36秒前
不吃汉堡完成签到,获得积分10
36秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
Grapes 1000
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8179592
求助须知:如何正确求助?哪些是违规求助? 9569910
关于积分的说明 21807526
捐赠科研通 7775056
什么是DOI,文献DOI怎么找? 3433072
关于科研通互助平台的介绍 2557032
邀请新用户注册赠送积分活动 2478760